or Try an Advanced Search...

    Technical Analysis for ITOS - iTeos Therapeutics, Inc.

    Grade Last Price % Change Price Change
    B 17.96 7.42% 1.24
    ITOS closed up 7.42 percent on Wednesday, May 15, 2024, on 1.53 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical ITOS trend table...
    Date Alert Name Type % Chg
    180 Bullish Setup Bullish Swing Setup 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Wide Bands Range Expansion 0.00%
    Above Upper BB Strength 0.00%
    Gapped Up Strength 0.00%
    Overbought Stochastic Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Upper Bollinger Band Walk Strength 7.42%
    Wide Bands Range Expansion 7.42%
    Above Upper BB Strength 7.42%
    Older End-of-Day Signals for ITOS ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 10 hours ago
    Rose Above Previous Day's High about 13 hours ago
    Up 1 ATR about 14 hours ago
    Up 5% about 14 hours ago
    Gap Up Partially Closed about 14 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ITOS Chart by TradingView
    Basic chart:

    Profile

    Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for cancer patients. Its product pipeline includes EOS-850, a small molecule antagonist of the adenosine A2a receptor; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains. The company was founded in 2011 and is based in Cambridge, Massachusetts with an additional location in Gosselies, Belgium.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Adenosine Therapeutics For Cancer

    Is ITOS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 10 iTeos Therapeutics signs agreement for $120M registered direct offering
    May 10 iTeos Therapeutics reports Q1 results
    May 10 iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates
    May 10 iTeos Therapeutics Announces $120 Million Registered Direct Offering
    May 10 iTeos shares jump on TIGIT update; Acelyrin swaps CEOs
    Apr 7 iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024
    Mar 6 Recap: ITeos Therapeutics Q4 Earnings
    Mar 6 iTeos Therapeutics GAAP EPS of -$0.85 beats by $0.18
    Mar 6 iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors
    Mar 6 iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
    See more ITOS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 18.75
    52 Week Low 8.2
    Average Volume 411,023
    200-Day Moving Average 11.13
    50-Day Moving Average 12.11
    20-Day Moving Average 12.47
    10-Day Moving Average 14.14
    Average True Range 1.06
    RSI (14) 78.81
    ADX 33.11
    +DI 49.18
    -DI 7.11
    Chandelier Exit (Long, 3 ATRs) 15.58
    Chandelier Exit (Short, 3 ATRs) 13.18
    Upper Bollinger Bands 17.46
    Lower Bollinger Band 7.47
    Percent B (%b) 1.05
    BandWidth 80.17
    MACD Line 1.36
    MACD Signal Line 0.62
    MACD Histogram 0.7385
    Fundamentals Value
    Market Cap 642.7 Million
    Num Shares 35.8 Million
    EPS -1.75
    Price-to-Earnings (P/E) Ratio -10.26
    Price-to-Sales 5.87
    Price-to-Book 0.64
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 19.60
    Resistance 3 (R3) 19.49 18.83 19.32
    Resistance 2 (R2) 18.83 18.42 18.89 19.23
    Resistance 1 (R1) 18.40 18.16 18.62 18.51 19.14
    Pivot Point 17.74 17.74 17.85 17.80 17.74
    Support 1 (S1) 17.31 17.33 17.53 17.42 16.78
    Support 2 (S2) 16.65 17.07 16.71 16.69
    Support 3 (S3) 16.22 16.65 16.60
    Support 4 (S4) 16.33